# Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration

> **NCT00100009** · PHASE3 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 30 (—)

## Conditions studied

- Macular Degeneration

## Interventions

- **DRUG:** TAC-PF
- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT00100009
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12-09
- **Primary completion:** —
- **Final completion:** 2006-12-20
- **Target enrollment:** 30 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100009, "Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00100009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*